• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J.

CMT4J is a severe form of Charcot-Marie-Tooth neuropathy caused by mutation of the phosphoinositide phosphatase FIG4/SAC3. Affected individuals are compound heterozygotes carrying the missense allele FIG4-I41T in combination with a null allele. Analysis using the yeast two-hybrid system demonstrated that the I41T mutation impairs interaction of FIG4 with the scaffold protein VAC14. The critical role of this interaction was confirmed by the demonstration of loss of FIG4 protein in VAC14 null mice. We developed a mouse model of CMT4J by expressing a Fig4-I41T cDNA transgene on the Fig4 null background. Expression of the mutant transcript at a level 5 × higher than endogenous Fig4 completely rescued lethality, whereas 2 × expression gave only partial rescue, providing a model of the human disease. The level of FIG4-I41T protein in transgenic tissues is only 2% of that predicted by the transcript level, as a consequence of the protein instability caused by impaired interaction of the mutant protein with VAC14. Analysis of patient fibroblasts demonstrated a comparably low level of mutant I41T protein. The abundance of FIG4-I41T protein in cultured cells is increased by treatment with the proteasome inhibitor MG-132. The data demonstrate that FIG4-I41T is a hypomorphic allele encoding a protein that is unstable in vivo. Expression of FIG4-I41T protein at 10% of normal level is sufficient for long-term survival, suggesting that patients with CMT4J could be treated by increased production or stabilization of the mutant protein. The transgenic model will be useful for testing in vivo interventions to increase the abundance of the mutant protein.

Pubmed ID: 21655088

Authors

  • Lenk GM
  • Ferguson CJ
  • Chow CY
  • Jin N
  • Jones JM
  • Grant AE
  • Zolov SN
  • Winters JJ
  • Giger RJ
  • Dowling JJ
  • Weisman LS
  • Meisler MH

Journal

PLoS genetics

Publication Data

June 9, 2011

Associated Grants

  • Agency: NIGMS NIH HHS, Id: R01 GM050403
  • Agency: NIGMS NIH HHS, Id: R01 GM24872
  • Agency: NINDS NIH HHS, Id: R01 NS064015
  • Agency: NINDS NIH HHS, Id: R01 NS64015
  • Agency: NINDS NIH HHS, Id: R56 NS04733
  • Agency: NIGMS NIH HHS, Id: T32 GM 008322
  • Agency: NIGMS NIH HHS, Id: T32 GM007544
  • Agency: NIGMS NIH HHS, Id: T32 GM07863

Mesh Terms

  • Alleles
  • Animals
  • Autophagy
  • Charcot-Marie-Tooth Disease
  • Fibroblasts
  • Flavoproteins
  • Gliosis
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Mice
  • Mice, Transgenic
  • Models, Animal
  • Mutation
  • Proteasome Endopeptidase Complex
  • Proteasome Inhibitors
  • Transfection